Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Role of circulating microRNAs in patients with dengue infection

ABSTRACT: Role of circulating microRNAs in patients with dengue infection

PROVIDER: PRJNA632945 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11792700.fastq.gz	Fastqsanger.gz
	SRR11792701.fastq.gz	Fastqsanger.gz
	SRR11792702.fastq.gz	Fastqsanger.gz
	SRR11792703.fastq.gz	Fastqsanger.gz
	SRR11792704.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 96

Similar Datasets

Role of circulating microRNAs in patients with dengue infection

Project description:miRNAs are found to be extremely stable in extracellular fluids of mammals, such as blood plasma, serum, etc. The expression profiles of these circulating miRNAs have immense potential for use as novel minimally invasive markers in monitoring Dengue diseases progression.

2020-08-25 | GSE150623 | GEO

Discovery and validation of circulating miRNAs for the clinical prognosis of severe dengue

Project description:Background: dengue is a potentially life-threatening viral infection. Early prognostic markers of severe complications may improve case management and reduce dengue-related mortalities. This study aimed to identify circulating microRNAs (miRNAs) as biomarkers for predicting severe dengue. Methods: Serum samples from dengue-infected patients were collected on the first day of admission. Patients were followed up for 14 days after admission to determine the final diagnosis. Participants were divided into non-severe and severe dengue, as defined by WHO 2009 criteria. Circulating microtranscriptome analysis was performed using the NanoString miRNA Expression Assay. The expression level of candidate miRNAs were then validated by quantitative reverse transcription-PCR (qRT-PCR) method. Findings: The discovery cohort (N=19) lead to the identification of 37 differentially expressed miRNAs between the two groups. Six miRNAs (miR122-5p, miR1246, miR1303, miR574-5p, miR30d-5p, and miR424-5p) were selected and further validated in the larger cohort (N=135). The qRT-PCR analysis confirmed that the six miRNAs expression levels were significantly higher in the severe dengue group compared to the non-severe group. Based on receiver operating characteristic (ROC) analysis, miR574-5p and miR1246 displayed the highest diagnostic performance in discriminating between severe from non-severe dengue (AROC curve =0·83). Additionally, miR574-5p and miR1246 had high sensitivity and high negative predictive value for detecting severe dengue. Multivariate analysis suggested that serum miR574-5p was an independent predictor of severe dengue (odds ratio 3·30, 95% CI 1·81-6·04; p<0·001). Interpretation: Circulating miRNAs, especially miR-574-5p and miR-1246, could be promising diagnostic and prognostic biomarkers for severe dengue.

2022-10-26 | GSE190749 | GEO

Nicaragua Dengue Natural Infection

Project description:These 40 microarray datasets represent whole blood samples from 31 primary dengue infection patients and 9 healthy volunteers from Managua, Nicaragua. The dengue infection patients include both primary dengue fever (DF) and primary dengue hemorrhagic fever (DHF) cases.

2018-07-31 | GSE96656 | GEO

Differential miRNome analysis in a dengue resistant cohort versus susceptible after Dengue Virus serotype 2 or mock in vitro infection

Project description:MicroRNAs have emerged as relevant players in resistance to infection. We aimed to identify miRNAs involved in natural resistance to dengue infection. Two groups of people living in dengue endemic area were classified as susceptible (SD) or resistant (RD) to dengue virus (DENV) infection according to their anti-DENV antibody status. We hypothesized that anti-DENV seronegative individuals may represent a population resistant to DENV infection. The miRNome from monocytes of 7 individuals of each group was assessed upon mock- or DENV-2 infection.Dysregulated miRNAs were chosen as candidates for functional studies.

2025-02-12 | E-MTAB-13628 | biostudies-arrayexpress

Fingerprint of circulating microRNAs identify acute ischemic stroke patients

Project description:Fingerprint of circulating microRNAs identify acute ischemic stroke patients

| PRJNA1073466 | ENA

Circulating microRNAs profile in patients with transthyretin variant amyloidosis

Project description:Circulating microRNAs profile in patients with transthyretin variant amyloidosis

| PRJNA629572 | ENA

Global transcriptional assessment of consecutive samples from patients with dengue infection with association to dengue virus IgG serostatus

Project description:Whole blood from patients with acute dengue infection (as determined with PCR) were assessed for global transcriptional changes during different stages of the disease with reference to dengue virus IgG status at study inclusion

2014-04-01 | GSE28988 | GEO

MicroRNAs profile in Human Circulating CD4+ T Cells in Patients with Atherosclerosis Obliterans：Healthy persons vs. patients

Project description:MicroRNAs profile of circulating CD4+ T Cells in Aged Patients with Atherosclerosis Obliterans comparing healthy persons without symptoms or lesion associated with atherosclerosis.

2022-02-15 | GSE196698 | GEO

Global transcriptional assessment of consecutive samples from patients with dengue infection with association to dengue virus IgG serostatus

2014-04-01 | E-GEOD-28988 | biostudies-arrayexpress

Circulating exosomal microRNAs are indicative of patients with biliary colic

Project description:Circulating exosomal microRNAs are indicative of patients with biliary colic

| PRJNA844898 | ENA